12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

  • Ainos AIMD stock increased by 84.7% to $1.33 during Tuesday's pre-market session. The company's market cap stands at $26.6 million.
  • Perspective Therapeutics CATX shares rose 20.0% to $0.54. The market value of their outstanding shares is at $150.4 million.
  • Amylyx Pharma AMLX stock rose 18.67% to $36.99. The market value of their outstanding shares is at $2.4 billion. As per the press release, Q4 earnings came out yesterday.
  • Navidea Biopharmaceutical NAVB shares increased by 18.29% to $0.32. The company's market cap stands at $10.3 million.
  • Paratek Pharmaceuticals PRTK stock rose 16.07% to $2.04. The company's market cap stands at $113.4 million.
  • Viracta Therapeutics VIRX stock moved upwards by 15.88% to $1.97. The company's market cap stands at $75.2 million. As per the press release, Q4 earnings came out yesterday.

Losers

  • INVO Bioscience INVO shares fell 23.8% to $0.45 during Tuesday's pre-market session. The company's market cap stands at $5.5 million.
  • China Pharma Holding CPHI stock decreased by 18.42% to $0.39. The company's market cap stands at $2.0 million.
  • OKYO Pharma OKYO stock declined by 16.59% to $1.76. The market value of their outstanding shares is at $38.3 million.
  • Axogen AXGN stock fell 12.36% to $6.6. The market value of their outstanding shares is at $279.0 million. The company's, Q4 earnings came out today.
  • Gelesis Holdings GLS stock fell 12.17% to $0.2. The company's market cap stands at $14.6 million.
  • Cingulate CING stock decreased by 12.13% to $1.16. The market value of their outstanding shares is at $13.1 million. The company's, Q4 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!